PREVACID (lansoprazole)
PEPTIC ULCER AGENTS·ZOLLINGER-ELLISON SYNDROME·+13
PD-RX PHARM
Indication
Helicobacter pylori gastritis
*Helicobacter pylori* gastritis is an infectious inflammatory disorder of the gastric mucosa caused by colonization with the microaerophilic, gram-negative bacterium *Helicobacter pylori*. Read more about Helicobacter pylori gastritis
325 drugs 142 manufacturers
Drugs that treat it
Common Helicobacter pylori gastritis therapies.
CLARITHROMYCIN
MACROLIDE ANTIBIOTICS·DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION·+28
AHP
LANSOPRAZOLE
PEPTIC ULCER AGENTS·ZOLLINGER-ELLISON SYNDROME·+13
AHP
LANSOPRAZOLE
PEPTIC ULCER AGENTS·ZOLLINGER-ELLISON SYNDROME·+13
XIROMED, LLC
OMEPRAZOLE
PEPTIC ULCER AGENTS·ZOLLINGER-ELLISON SYNDROME·+10
XIROMED, LLC
LANSOPRAZOLE
PEPTIC ULCER AGENTS·ZOLLINGER-ELLISON SYNDROME·+13
Padagis US
OMEPRAZOLE
PEPTIC ULCER AGENTS·ZOLLINGER-ELLISON SYNDROME·+10
Padagis US
OMEPRAZOLE
PEPTIC ULCER AGENTS·ZOLLINGER-ELLISON SYNDROME·+10
FT-STRATEGIC SO
ESOMEPRAZOLE MAGNESIUM
PEPTIC ULCER AGENTS·ZOLLINGER-ELLISON SYNDROME·+9
L Perrigo Company
Filter & compare in the drug finder →Opens the drug finder with Helicobacter pylori gastritis preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soon*Helicobacter pylori* gastritis is an infectious inflammatory disorder of the gastric mucosa caused by colonization with the microaerophilic, gram-negative bacterium *Helicobacter pylori*.
Primarily affecting the gastrointestinal system, it is widespread across global pediatric and adult populations, often persisting indefinitely if untreated.
Pathophysiologically, bacterial virulence factors and urease production promote mucosal injury and stimulate a chronic inflammatory response marked by neutrophilic and mononuclear epithelial infiltration.
While frequently asymptomatic, the condition can present with dyspepsia or epigastric discomfort and may progress to mucosal atrophy, intestinal metaplasia, peptic ulcer disease, or gastric malignancy.
- nih.gov
*Helicobacter pylori* gastritis is an infectious inflammatory disorder of the gastric mucosa caused by colonization with the microaerophilic, gram-negative bacterium *Helicobacter pylori* Primarily affecting the gastrointestinal system, it is widespread across global pediatric and adult populations, often persisting indefinitely if untreated While frequently asymptomatic, the condition can present with dyspepsia or epigastric discomfort and may progress to mucosal atrophy, intestinal metaplasia,...
- nih.gov
*Helicobacter pylori* gastritis is an infectious inflammatory disorder of the gastric mucosa caused by colonization with the microaerophilic, gram-negative bacterium *Helicobacter pylori* Pathophysiologically, bacterial virulence factors and urease production promote mucosal injury and stimulate a chronic inflammatory response marked by neutrophilic and mononuclear epithelial infiltration
- nih.gov
*Helicobacter pylori* gastritis is an infectious inflammatory disorder of the gastric mucosa caused by colonization with the microaerophilic, gram-negative bacterium *Helicobacter pylori*
- nih.gov
Primarily affecting the gastrointestinal system, it is widespread across global pediatric and adult populations, often persisting indefinitely if untreated While frequently asymptomatic, the condition can present with dyspepsia or epigastric discomfort and may progress to mucosal atrophy, intestinal metaplasia, peptic ulcer disease, or gastric malignancy
- nih.gov
Pathophysiologically, bacterial virulence factors and urease production promote mucosal injury and stimulate a chronic inflammatory response marked by neutrophilic and mononuclear epithelial infiltration
- nih.gov
Pathophysiologically, bacterial virulence factors and urease production promote mucosal injury and stimulate a chronic inflammatory response marked by neutrophilic and mononuclear epithelial infiltration
- nih.gov
Pathophysiologically, bacterial virulence factors and urease production promote mucosal injury and stimulate a chronic inflammatory response marked by neutrophilic and mononuclear epithelial infiltration While frequently asymptomatic, the condition can present with dyspepsia or epigastric discomfort and may progress to mucosal atrophy, intestinal metaplasia, peptic ulcer disease, or gastric malignancy
Personalize your experience
Follow Helicobacter pylori gastritis and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.